Phibro Animal Health Corp. A buy JPMorgan Chase & Co.
Start price
07.07.25
/
50%
€25.80
Target price
07.07.26
€29.73
Performance (%)
34.26%
Price
12.12.25
€34.40
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Phibro Animal Health Corp. A has seen massive gains of 34.26%. A total of €0.24 was paid as dividends for this prediction. This prediction currently runs until 07.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Phibro Animal Health Corp. A | -0.578% | -0.578% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Phibro Animal Health Corp. A diskutieren
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Ratings data for PAHC provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Phibro Animal Health Corp. A
Phibro Animal Health Corp. A
Start price
Target price
Perf. (%)
€38.40
07.11.25
07.11.25
€43.34
07.11.26
07.11.26
-10.63%
12.12.25
12.12.25
